Newsroom

Experimental contraceptive could give women the power to prevent pregnancy and STIs


November 30, 2018

Nongnuj TanphaichitrWhile condoms are the gold standard for preventing pregnancy and Sexually Transmitted Infections (STIs), there is a need around the world for solutions that can be used independently by women. New research led by Dr. Nongnuj Tanphaichitr brings a potential solution closer to reality.

More than a decade ago, Dr. Tanphaichitr discovered a natural peptide called LL-37 that can kill sperm as well as microbes such as HIV. Her team’s new paper in Human Reproduction shows that shorter versions of LL-37, which would be cheaper to manufacture, are just as effective. Treatment with the shorter peptides completely eliminated the ability of mouse sperm to fertilize eggs. The peptides also killed the bacteria that cause gonorrhea, which are increasingly resistant to antibiotics. They had no effect on female reproductive tissues and minimal effects on resident bacteria, lactobacilli, which maintain vaginal health.

Her team is now looking at ways to deliver the peptide using nanoparticles.

“While condoms are the gold standard for preventing pregnancy and sexually transmitted infections, we also need solutions that women can use independently,” said Dr. Nongnuj Tamphaichitr, senior scientist at The Ottawa Hospital and professor at the University of Ottawa. “Our research could provide this.”

Authors: Kiattiburut W, Zhi R, Lee SG, Foo AC, Hickling DR, Keillor JW, Goto NK, Li W, Conlan W, Angel JB, Wang G, Tanphaichitr N.

Funding: Dr. Tanphaichitr’s research is possible because of generous support from the community for research at The Ottawa Hospital. This study was also funded by the Canadian Institutes of Health Research and the National Institutes of Health.

The Ottawa Hospital: Inspired by research. Driven by compassion 

The Ottawa Hospital is one of Canada’s largest learning and research hospitals with over 1,100 beds, approximately 12,000 staff and an annual budget of over $1.2 billion. Our focus on research and learning helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital, affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care. See www.ohri.ca for more information about research at The Ottawa Hospital.

University of Ottawa: —A crossroads of cultures and ideas

The University of Ottawa is home to over 50,000 students, faculty and staff, who live, work and study in both French and English. Our campus is a crossroads of cultures and ideas, where bold minds come together to inspire game-changing ideas. We are one of Canada’s top 10 research universities—our professors and researchers explore new approaches to today’s challenges. One of a handful of Canadian universities ranked among the top 200 in the world, we attract exceptional thinkers and welcome diverse perspectives from across the globe. www.uottawa.ca

Media Contact

Jennifer Ganton
Director, Communications and Public Relations
Ottawa Hospital Research Institute
Office: 613-798-5555 x 73325
Cell: 613-614-5253
jganton@ohri.ca

 

Scientific Program tags: Inflammation and Chronic Disease Program